CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)
Completed · Phase 3 · Has a placebo group
Conditions studied: Asthma
In brief
Asthma affects about 4 million children in the United States and is a leading cause of hospitalizations and school absenteeism. Continuous wheezing in very young children may develop into asthma. Low doses of inhaled corticosteroids (ICS) are commonly prescribed to treat children with particularly bad wheezing episodes. This study will compare the safety and effectiveness of low doses of ICS taken daily versus higher doses of ICS taken only during respiratory tract illnesses for toddlers with continuous wheezing or coughing illnesses.
Key facts
- Study ID
- NCT00675584
- Run by
- Milton S. Hershey Medical Center
- People needed
- 278
- Starts
- 2008-08-01
- Expected to finish
- 2010-07-01
- Last updated by the study team
- 2018-06-26
Who can join
Age: 1 and older, up to 4. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Arizona College of Medicine — Tucson, Arizona, United States
- Kaiser Permanente Medical Center — San Diego, California, United States
- National Jewish Medical and Research Center — Denver, Colorado, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- University of Wisconsin - Madison — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.